<DOC>
<DOCNO>EP-0624092</DOCNO> 
<TEXT>
<INVENTION-TITLE>
UTILIZATION OF NIOBIUM DERIVATIVES AS ACTIVE PRINCIPLE OF MEDICAMENTS USEFUL IN THE TREATMENT AND/OR PREVENTION OF GLUCID AND/OR LIPID METABOLIUM TROUBLES.
</INVENTION-TITLE>
<CLASSIFICATIONS>A61K3128	A61K3128	A61K3324	A61K3324	C07C3500	C07C3516	C07C33300	C07C33316	C07D21300	C07D21380	C07D24300	C07D24308	C07D29500	C07D29521	C07F900	C07F900	C07F9117	C07F990	C07F1100	C07F1100	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>A61K	A61K	A61K	A61K	C07C	C07C	C07C	C07C	C07D	C07D	C07D	C07D	C07D	C07D	C07F	C07F	C07F	C07F	C07F	C07F	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>A61K31	A61K31	A61K33	A61K33	C07C35	C07C35	C07C333	C07C333	C07D213	C07D213	C07D243	C07D243	C07D295	C07D295	C07F9	C07F9	C07F9	C07F9	C07F11	C07F11	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
The invention relates to a new utilization of niobium derivatives in the 4 or 5 oxidation status as active principle for the production of medicaments useful in the treatment and/or prevention of glucid and/or lipid metabolism troubles. The niobium derivatives useful according to the invention are in the form of mineral salts or organometallic salts or complexes. The medicaments are useful for the treatment of diabetes, hypercholesterolemy, hyperlipidemy, hypertriglyceridemy and complications associated to said pathologies.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
</TEXT>
</DOC>
